Huinan Changlong Bio-Pharmacy schedules board meeting to review interim results

PUBT · 1d ago
Huinan Changlong Bio-Pharmacy schedules board meeting to review interim results
  • Jilin Province Huinan Changlong Bio-Pharmacy will hold a board meeting on Aug. 14, 2026 at 10:00 a.m.
  • Directors will review unaudited interim results for the six months ended June 30, 2026.
  • Agenda includes consideration of an interim dividend, if any, plus possible share register closure.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12271739), on August 04, 2026, and is solely responsible for the information contained therein.